Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
Autor: | Mesnage, S.J.L., Auguste, A., Genestie, C., Dunant, A., Pain, E., Drusch, F., Gouy, S., Morice, P., Bentivegna, E., Lhomme, C., Pautier, P., Michels, J., Le Formal, A., Cheaib, B., Adam, J., Leary, A.F. * |
---|---|
Zdroj: | In Annals of Oncology March 2017 28(3):651-657 |
Databáze: | ScienceDirect |
Externí odkaz: |